4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-001396
CHIEF FINANCIAL OFFICER acquired 2,592 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 2024-12-31 | Grant or award | +2,592 | $2.51 | $6,499 | 6,184 | D |
Loading xslF345X05/form4-01132025_100126.xml…